These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30417788)

  • 1. Epidemics and Peptide Vaccine Response: A Brief Review.
    Nandy A; Dey S; Roy P; Basak SC
    Curr Top Med Chem; 2018; 18(26):2202-2208. PubMed ID: 30417788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced surveillance and response approaches for pilgrims and local Saudi populations against emerging Nipah, Zika and Ebola viral diseases outbreaks threats.
    Tambo E; El-Dessouky AG; Khater EIM; Xianonng Z
    J Infect Public Health; 2020 May; 13(5):674-678. PubMed ID: 32265162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.
    Zumbrun EE
    Vet Pathol; 2015 Jan; 52(1):18-20. PubMed ID: 25352204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebola and Zika: Cautionary tales.
    Osterholm MT
    Science; 2016 Sep; 353(6304):1073. PubMed ID: 27609862
    [No Abstract]   [Full Text] [Related]  

  • 5. Billion-dollar project aims to prep vaccines before epidemics hit.
    Butler D
    Nature; 2017 Jan; 541(7638):444-445. PubMed ID: 28128262
    [No Abstract]   [Full Text] [Related]  

  • 6. Virology. A henipavirus vaccine in sight.
    von Messling V; Cattaneo R
    Science; 2012 Aug; 337(6095):651-2. PubMed ID: 22879489
    [No Abstract]   [Full Text] [Related]  

  • 7. A Computational Approach for Designing a Universal Epitope-Based Peptide Vaccine Against Nipah Virus.
    Ali MT; Morshed MM; Hassan F
    Interdiscip Sci; 2015 Jun; 7(2):177-85. PubMed ID: 26156209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEPI: Driving Progress Toward Epidemic Preparedness and Response.
    Gouglas D; Christodoulou M; Plotkin SA; Hatchett R
    Epidemiol Rev; 2019 Jan; 41(1):28-33. PubMed ID: 31673694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bioinformatics approach to designing a Zika virus vaccine.
    Dey S; Nandy A; Basak SC; Nandy P; Das S
    Comput Biol Chem; 2017 Jun; 68():143-152. PubMed ID: 28342423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a vaccine against Ebola virus.
    Geisbert TW; Jahrling PB
    Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities.
    Nie J; Liu L; Wang Q; Chen R; Ning T; Liu Q; Huang W; Wang Y
    Emerg Microbes Infect; 2019; 8(1):272-281. PubMed ID: 30866781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.
    Krubiner CB; Faden RR; Karron RA; Little MO; Lyerly AD; Abramson JS; Beigi RH; Cravioto AR; Durbin AP; Gellin BG; Gupta SB; Kaslow DC; Kochhar S; Luna F; Saenz C; Sheffield JS; Tindana PO;
    Vaccine; 2021 Jan; 39(1):85-120. PubMed ID: 31060949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of DNA immunization with F and G protein genes of Nipah virus.
    Wang X; Ge J; Hu S; Wang Q; Wen Z; Chen H; Bu Z
    Ann N Y Acad Sci; 2006 Oct; 1081():243-5. PubMed ID: 17135518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging infectious diseases. Nipah virus (or a cousin) strikes again.
    Enserink M
    Science; 2004 Feb; 303(5661):1121. PubMed ID: 14976284
    [No Abstract]   [Full Text] [Related]  

  • 16. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.
    Mungall BA; Middleton D; Crameri G; Bingham J; Halpin K; Russell G; Green D; McEachern J; Pritchard LI; Eaton BT; Wang LF; Bossart KN; Broder CC
    J Virol; 2006 Dec; 80(24):12293-302. PubMed ID: 17005664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola virus: from discovery to vaccine.
    Feldmann H; Jones S; Klenk HD; Schnittler HJ
    Nat Rev Immunol; 2003 Aug; 3(8):677-85. PubMed ID: 12974482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
    Zhou Y; Sullivan NJ
    Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.